Ernesto P Gidaya, MD | |
1111 W La Palma Ave, Anaheim, CA 92801-2804 | |
(714) 774-1450 | |
(714) 710-7741 |
Full Name | Ernesto P Gidaya |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 46 Years |
Location | 1111 W La Palma Ave, Anaheim, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003873522 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | A38770 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesia Specialists Of Orange County, Inc. | 9830289388 | 17 |
News Archive
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests and remain free of cardiac events.
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2011.
NephRx Corporation today announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients.
Researchers from Toronto, Canada, performed a cohort study to analyze the impact of COVID-19 vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and clinical outcomes in kidney transplant patients. This study is available on the preprint server, medRxiv.
› Verified 6 days ago
Entity Name | Anesthesia Specialists Of Orange County, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134311319 PECOS PAC ID: 9830289388 Enrollment ID: O20071220000220 |
News Archive
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests and remain free of cardiac events.
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2011.
NephRx Corporation today announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients.
Researchers from Toronto, Canada, performed a cohort study to analyze the impact of COVID-19 vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and clinical outcomes in kidney transplant patients. This study is available on the preprint server, medRxiv.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Ernesto P Gidaya, MD 1211 W La Palma Ave Ste 209, Anaheim, CA 92801-2802 Ph: (714) 710-7731 | Ernesto P Gidaya, MD 1111 W La Palma Ave, Anaheim, CA 92801-2804 Ph: (714) 774-1450 |
News Archive
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests and remain free of cardiac events.
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2011.
NephRx Corporation today announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients.
Researchers from Toronto, Canada, performed a cohort study to analyze the impact of COVID-19 vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and clinical outcomes in kidney transplant patients. This study is available on the preprint server, medRxiv.
› Verified 6 days ago
Ms. Bich Ngoc Dang, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3033 W Orange Ave, Anaheim, CA 92804 Phone: 714-827-3000 Fax: 949-588-2199 | |
Roxanne S. Tagayun, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Donny Chung, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dr. Claudia Marie Nuno Garcia, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1741 W Romneya Dr, Ste B, Anaheim, CA 92801 Phone: 714-332-5000 Fax: 714-833-5007 | |
Nhat D. Le, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dorothy M Toung, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |